1,024 filings
Page 9 of 52
4
Michael H. Davidson
10 Sep 20
CALADRIUS BIOSCIENCES / Michael H. Davidson ownership change
4:01pm
424B3
LSTA
Lisata Therapeutics Inc
2 Sep 20
Prospectus supplement
4:03pm
EFFECT
LSTA
Lisata Therapeutics Inc
28 Aug 20
Notice of effectiveness
12:15am
UPLOAD
LSTA
Lisata Therapeutics Inc
25 Aug 20
Letter from SEC
12:00am
CORRESP
LSTA
Lisata Therapeutics Inc
25 Aug 20
Correspondence with SEC
12:00am
S-8
LSTA
Lisata Therapeutics Inc
18 Aug 20
Registration of securities for employees
4:05pm
S-3
LSTA
Lisata Therapeutics Inc
Shelf registration
18 Aug 20
4:02pm
10-Q
2020 Q2
LSTA
Lisata Therapeutics Inc
Quarterly report
13 Aug 20
4:10pm
8-K
LSTA
Lisata Therapeutics Inc
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
4
Michael H. Davidson
12 Aug 20
CALADRIUS BIOSCIENCES / Michael H. Davidson ownership change
9:21am
3
Michael H. Davidson
12 Aug 20
CALADRIUS BIOSCIENCES / Michael H. Davidson ownership change
9:19am
8-K
LSTA
Lisata Therapeutics Inc
5 Aug 20
Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer
4:07pm
8-K
LSTA
Lisata Therapeutics Inc
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
D
LSTA
Lisata Therapeutics Inc
27 Jul 20
$2M in options / securities to be acquired, sold $2M, 3 investors
9:28am
SC 13G
Greenfield Children LLC
21 Jul 20
CALADRIUS BIOSCIENCES / GREENFIELD CHILDREN ownership change
11:34am
8-K
LSTA
Lisata Therapeutics Inc
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
EFFECT
LSTA
Lisata Therapeutics Inc
30 Jun 20
Notice of effectiveness
12:02am
424B3
LSTA
Lisata Therapeutics Inc
29 Jun 20
Prospectus supplement
12:00am
CORRESP
LSTA
Lisata Therapeutics Inc
25 Jun 20
Correspondence with SEC
12:00am
UPLOAD
LSTA
Lisata Therapeutics Inc
25 Jun 20
Letter from SEC
12:00am